Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Polycythemia Vera × Polymerase Chain Reaction × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Leukemia 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Lymphoma 4 Congenital Abnormalities 4 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lung Neoplasms 2 Leukemia, Myeloid, Accelerated Phase 2 Kidney Neoplasms 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 HIV Infections 2

Interventions

fludarabine phosphate 16 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 ruxolitinib 8 Busulfan 8 Cyclophosphamide 7 Tacrolimus 6 fludarabine 5 Melphalan 5 Cyclosporine 5 Methotrexate 4 Antilymphocyte Serum 4 givinostat hydrochloride 3 givinostat 3 Lenalidomide 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 thymoglobulin 2 pomalidomide 2 Surveys and Questionnaires 2 Stem Cell Transplantation 2 Prednisone 2 Hydroxyurea 2 Etoposide 2 Dasatinib 2 Carboplatin 2 veliparib 1 sonidegib 1 pembrolizumab 1 peginterferon alfa-2a 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡